N itric oxide (NO) is a multifunctional molecule
that mediates a number of diverse physiologic processes, including vasodilatation, neurotransmission, antimicrobial effect, and immunomodulation (1,2). It is formed from the oxidation of L-arginine by nitric oxide synthase (NOS). Three distinct NOS have been identified and cloned from rodents and humans (3) . The neuronal or type I NOS (nNOS) and the endothelial, or type III, NOS (eNOS) are constitutively expressed and require the presence of extracellular calcium (3). The inducible, or type II, NOS (iNOS) can be variably induced by cytokines and microbial products, primarily by transcriptional control (3) . Many human cell types have been reported to express iNOS after lipopolysaccharide (LPS) and cytokine treatment (3) . The levels of NO in peritoneal dialysate effluent increase during the acute phase of peritonitis and are probably the result of local NO production (4, 5) . When patients have refractory peritonitis caused by fungus or gram-negative bacilli, NO levels in dialysate effluent remain elevated for as long as the inflammation persists (6) . It has been reported that addition of N G -nitro-L-arginine methyl ester (L-NAME), an inhibitor of NOS, to peritoneal dialysate reduced both local and systemic production of NO and increased the selectivity of the peritoneum and the net ultrafiltration during dialysis (7). These results imply that intraperitoneal NO participates in the inflammatory reaction and is involved in the modulation of peritoneal permeability during peritonitis. However, the definite source of local NO production during peritonitis remained undetermined. Previous reports have pointed out that endothelial cells of peritoneal vasculatures or peritoneal macrophages might be sources (8, 9) . Although rat pleural mesothelial cell line (4/4 RM-4) has been shown to produce NO after stimulation by combinations of cytokines and LPS (10), whether human peritoneal mesothelial cells (HPMC) can produce NO has not been investigated.
During peritonitis, increased levels of tumor necrosis factor alpha (TNFα), interleukin-1 beta (IL-1β), PDI NOVEMBER 2000 -VOL. 20, NO. 6 NITRIC OXIDE PRODUCTION BY MESOTHELIAL CELLS and interferon gamma (IFNγ) were found in peritoneal dialysate effluent (11, 12) . HPMC can respond to the stimulation of these inflammatory cytokines by producing mediators to modulate intraperitoneal inflammation (13) . Therefore, we hypothesize that these cytokines and bacterial components such as LPS could induce iNOS in HPMC, and subsequently increase local NO production during peritonitis.
MATERIALS AND METHODS

MESOTHELIAL CELL CULTURE AND CYTOKINE T R E A T M E N T
HPMC were obtained from human omentum according to the method of Stylianou et al. (14) . Omentum collected from consenting nonuremic patients undergoing elective abdominal surgery was incubated in 0.05% (w/v) trypsin and 0.01% (w/v) EDTA for 20 minutes at 37°C. The harvested mesothelial cells were centrifuged at 1000 rpm for 5 minutes, then resuspended in M199 (Sigma, St. Louis, MO, U.S.A.) containing 10% fetal calf serum (FCS, Life Technologies, Grand Island, NY, U.S.A.). Media were supplemented with insulin 0.5 μg/mL, transferrin 0.5 μg/mL, penicillin 100 U/mL, streptomycin 100 mg/mL, and L-glutamine 2 mmol/L. Cells were seeded in 25-cm 2 plastic flasks (Nalge Nunc International, Naperville, IL, U.S.A.) and cultured in 5% CO 2 at 37°C. Mesothelial cells were characterized by positive immunofluorescence stain for cytokeratin and vimentin. These cells did not express factor VIII, desmin, or UEA-I. Transmission electron microscopy also showed the presence of numerous surface microvilli, pinocytotic vesicles, and abundant cytoplasmic microfilaments. All experiments were performed with cells from the second or third passage.
For cytokine treatment, cells were grown in 6-and 24-well plates (Nalge Nunc International) at a density of 3 × 10 5 and 6 × 10 4 cells/well with DMEM (Sigma) containing 10% FCS. After reaching confluence, HPMC were incubated in DMEM, containing 0.1% FCS, for 48 hours prior to cytokine and LPS stimulation. Then HPMC monolayers were exposed to DMEM with 0.1% FCS containing TNFα, IL-1β, IFNγ (R & D Systems, Minneapolis, MN, U.S.A.) and LPS (from E. coli, serotype 0111: B4, Sigma), individually or in various double and triple combinations, for 24 -72 hours. Concentrations of cytokines and LPS used were determined from preliminary studies. DMEM + 0.1% FCS was used as control medium.
NITRATE/NITRITE ASSAY
At the end of the incubation period, the culture media were removed and frozen at -70°C for later analysis, and HPMC were trypsinized and counted in a hemocytometer.
In cell culture systems, the majority of NO produced is converted into nitrite and nitrate by reaction with ambient oxygen (mostly in the form of nitrate). Therefore, we measured nitrite accumulation using the Griess method (15) as an index of NO production. Briefly, nitrate was first reduced to nitrite with nitrate reductase, then culture media were incubated with an equal volume of Griess reagent composed of 2.9 mmol/L sulfanilic acid and 0.2 mmol/L N-(1-naphthyl) ethylenediamine hydrochloride in 5% phosphatic acid. The colored product of the diazotization reaction was spectrophotometrically quantified at 540 nm using a microplate ELISA reader. Sodium nitrite dissolved in the same medium was used as standard. The experiments were performed four times using HPMC prepared from different donors.
RT-PCR ANALYSIS OF iNOS AND eNOS EXPRESSION
For reverse transcriptase-polymerase chain reaction (RT-PCR) assay, total RNA was extracted using a commercial kit (RNAzol B, Tel-test Inc., Friendswood, TX, U.S.A.) according to the method of Chomzynski and Sacchi (16) . Briefly, cells were lysed with the acid guanidinium thiocyanate and RNA was extracted with chloroform and then precipitated by isopropanol. RNA was washed in 75% ethanol, then dissolved in DEPC-treated water and stored at -70°C until required. First-strand cDNA was synthesized from 5 μg total RNA with Superscript II RNAse H -RT (Life Technologies) using oligo (dT) as primers. PCR amplification from reverse-transcribed cDNA was carried out using PCR primers for iNOS and eNOS: iNOS sense 5′-GAGCTTCTACCTCAAGCTATC-3′ iNOS antisense 5′-CCTGATGTTGCCATTGTTGGT-3′ (313-bp product) (17); eNOS sense 5′-GCACAGGAAATGTTCACCTAC-3′ eNOS antisense 5′-CACGATGGTGACTTTGGCTAG-3′ (654-bp product) (18) .
PCR amplification of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was carried out on the same samples as a parallel control:
GAPDH sense 5′-CCACCCATGGCAAATTCCATGGCA-3′ GAPDH antisense 5′-TCAAGACGGCAGGTCAGGTCCACC-3′ (598-bp product) (19) .
PCR amplification was carried out in a total reaction volume of 25 μL. A volume of 1 μL cDNA from the 20 μL reverse-transcribed product was added to each reaction mixture and amplified with Taq polymerase (Takara, Shiga, Japan). Amplification was performed with a thermal cycler 2400 (Perkin-Elmer, Norwalk, CT, U.S.A.); the reaction cycles were an initial denaturation step of 4 minutes at 94°C, followed by denaturation at 94°C for 30 seconds, annealing at 55°C (eNOS) or 62°C (iNOS, GAPDH) for 30 seconds, and extension at 72°C for 30 seconds, followed by 5 minutes extension at 72°C. The numbers of amplification cycles were 35 (iNOS and eNOS) and 25 (GAPDH). Electrophoresis of the amplified products was performed on 1% agarose gel containing Tris acetate/EDTA buffer. A 100-bp ladder (Life Technologies) was used as a molecular size standard. Gels were visualized with UV irradiation and photographed. PCR products were also sequenced and verified.
WESTERN BLOT ANALYSIS OF iNOS PROTEIN
After exposure to cytokines, HPMC monolayers were washed three times with phosphate buffered saline (PBSA) and lysed with lysis buffer (25 mmol/L Tris, 10 μg/mL aprotinin, 10 μg/mL leupeptin, 2 mmol/L phenylmethylsulfonylfluoride, 4 mmol/L EDTA, 4 mmol/L EGTA, and 1% Triton X-100) by sonication for 10 seconds. The lysates were then spun at 12 500g for 15 minutes and protein concentration was measured using Bradford's method (20) . An aliquot of 50 μg total protein was separated on a 7.5% SDS-polyacrylamide gel and transferred to a nitrocellulose membrane. Membranes were blocked overnight at 4°C with 5% nonfat dry milk in PBS containing 0.1% Tween 20 and then incubated with a polyclonal rabbit antibody against iNOS (AHP303, Serotec, Oxford, U.K.) for 1 hour at room temperature. The membranes were subsequently incubated with peroxidase-conjugated goat antirabbit IgG (P0448, Dako, Denmark) for 1 hour. Immunoblots were visualized by enhanced chemiluminescence (Supersignal, Pierce, Rockford, IL, U.S.A.) recorded on Kodak X-OMAT film. Lysate prepared from RAW 264.7 cell line stimulated with IFNγ (10 ng/mL) and LPS (1 μg/mL) for 12 hours was used as positive control for iNOS protein.
STATISTICAL ANALYSES
Results are expressed as mean ± SEM. Two-way ANOVA was used to determine the differences in the serial changes of nitrate/nitrite in different groups. Post hoc Bonferroni procedure was used to determine pair-wise difference. Differences were considered significant at p less than 0.05.
R E S U L T S
NITRATE/NITRITE MEASUREMENT HPMC treated with various cytokines for 24 -72 hours showed that a single cytokine or LPS was unable to induce NO production. Double combinations could induce significant NO production only when TNFα (5 ng/mL) + IFNγ (5 ng/mL) was used. This increase could be detected after 24 hours' incubation and the levels of NO increased with time ( Figure 1) . When HPMC monolayers were exposed to triple combinations of LPS and cytokines, only TNFα (5 ng/mL) + IFNγ (5 ng/mL) + IL-1β (5 ng/mL) induced more NO production than TNFα (5 ng/mL) + IFNγ (5 ng/mL) (27.27 ± 2.14 nmol/10 6 cells vs 15.31 ± 0.59 nmol/10 6 cells, p < 0.01) (Figure 2 ). After incubating in TNFα (5 ng/mL) + IFNγ (5 ng/mL) for 48 hours, the production of iNOS protein (130 kDa) was detected in HPMC ( Figure 5 ).
RT-PCR ANALYSIS
RT-PCR analysis revealed that there is no constitutive iNOS or eNOS expression in HPMC (
DISCUSSION
During peritonitis, increased intraperitoneal NO levels probably come from local induction of NOS in the peritoneal cavity (4, 5) . Previous reports pointed out that endothelial cells of peritoneum vasculatures or peritoneal macrophages might be the source of intraperitoneal NO during peritonitis (8, 9) . Using Western blot, upregulation of eNOS has been demonstrated in the human peritoneum during peritonitis (8) , and increased eNOS and iNOS activities of peritoneum were inversely correlated with free-water permeability in a rat peritonitis model (21) . Plum et al. reported that peritoneal macrophages from peri- tonitis patients could produce NO constitutively, but only small additional amounts of NO could be stimulated with LPS + IFNγ (9) . Because elevated levels of TNFα, IL-1β, and IFNγ were found in the dialysate effluent during peritonitis (11, 12) , the demonstration of synergistic induction of iNOS in cultured HPMC by TNFα + IFNγ strongly implies that HPMC might be an important source of NO in the peritoneal cavity. Due to its close proximity to peritoneal vessels, HPMC could effectively modulate their permeability via this system during peritonitis.
It is known that there is a role for iNOS in host defense because mice deficient in the iNOS gene have impaired bactericidal ability (22) . Many reports also revealed that NO contributes to tissue destruction in inflammatory/autoimmune diseases and that the magnitude of iNOS expressed in inflamed tissue correlates with disease activity (23) . Our preliminary experiments show that exogenous NO is toxic to cultured HPMC (data not shown), therefore, whether NO from HPMC is beneficial to the peritoneal host defense or is a mediator of cell damage during peritonitis remains to be clarified.
Our results showed that a single cytokine did not induce iNOS in HPMC and the combination of TNFα and IFNγ had a synergistic effect. The combination of TNFα + IFNγ + IL-1β induced even higher levels of NO production than did TNFα + IFNγ. However, in rat pleural mesothelial cell line 4/4 RM-4, significant NO production can be induced by IL-1β alone or by the combinations of any two of LPS, IFNγ, TNFα, and IL-1β (10) . The amount of NO produced by the rat pleural mesothelial cell line is also more than that produced by HPMC (142 ± 1 nmol/10 6 cells after stimulation with TNFα + IFNγ + LPS for 48 hours in rat pleural mesothelial cell line, vs 27.27 ± 2.14 nmol/ 10 6 cells after stimulation with TNFα + IFNγ + IL-1β for 72 hours in HPMC) (10) . On the contrary, in human pleural mesothelioma cell lines, although TNFα + IFNγ has a stronger antiproliferative effect than IFNγ alone, there was no iNOS induction after cytokine treatment (24) . Therefore, our results suggest that the induction pattern of iNOS in HPMC is different from that in rat and human pleural mesothelioma cell lines. Several lines of evidence indicated that the induction pattern of iNOS might differ between different tissue types and species. For example, murine macrophages could be induced to produce a large amount of NO (25) , while human monocyte iNOS was hard to induce or could be induced to produce only a low level of NO after cytokine stimulation (26) . In addition, a single cytokine or LPS could induce iNOS in rat mesangial cells (27) , but the combination of IL-1β and IFNγ was usually required for human mesangial cells to produce NO (28) . These differences probably come from different transcriptional control.
Human iNOS and murine iNOS share 80% sequence identity, but there are differences in their promoter regions.
Zhang et al. demonstrated two explanations for hyporesponsiveness of the human iNOS promoter to LPS ± IFNγ stimulation in a U937 cell line (29) : multiple inactivating nucleotide substitution in the enhancer element of human iNOS that was shown to regulate LPS/IFNγ-induced expression of murine iNOS; human macrophages lack one or more nuclear factors [e.g., a LPS-inducible nuclear factor kappa B (NFκB)/Rel complex] necessary for maximal iNOS expression after LPS + IFNγ stimulation in murine macrophages. Therefore, the lower production of NO in HPMC probably also results from different transcriptional regulations compared to that of the rat pleural mesothelial cell line. In terms of the lack of induction of iNOS by cytokines in human pleural mesothelioma cell lines, whether it was because the authors used immortalized cell lines instead of cultured primary pleural mesothelial cells is not known.
Our results showed that, using RT-PCR, iNOS mRNA can be detected 4 hours after stimulation with cytokines in HPMC. A previous report revealed that, in cultured human hepatocytes, iNOS mRNA can be detected by Northern blot 4 hours after stimulation with cytokines and LPS (30) . However, the results of RT-PCR and Northern blot may not be comparable.
As for the mechanism of synergistic induction of iNOS by TNFα and IFNγ, it has been shown that, in the RAW 264.7 cell line, the action is mediated by interaction of NFκB and interferon regulatory factor-1 (IRF-1), which are activated by TNFα and IFNγ, respectively (31) . Similar mechanisms might also exist in HPMC.
Usually, one cell type expresses only one constitutive or one inducible isoform of NOS; however, the endothelial cell is exceptional and can express both constitutive (eNOS) and inducible (iNOS) isoforms (32) . Our results demonstrated that there is no constitutive eNOS expression in HPMC, and this result also indicates that there is no endothelial cell contamination in our culture system.
In conclusion, our study provides new evidence for the sources of increased NOS activity of peritoneum during peritonitis. Since NO is a molecule with multiple functions, further study is necessary to elucidate the effects of NO production by HPMC.
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